We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STHO icon
1501
Star Holdings Shares of Beneficial Interest
STHO
$112M
$162K 0.01%
21,395
+10,974
+105% +$90.4K
XYF
1502
X Financial
XYF
$192M
$162K 0.01%
39,280
-17,276
-31% -$89.6K
MGNI icon
1503
Magnite
MGNI
$2.73B
$159K 0.01%
13,347
-3,176
-19% -$42.6K
DLTH icon
1504
Duluth Holdings
DLTH
$162M
$158K 0.01%
50,114
+23,704
+90% +$57.1K
SAIL
1505
SailPoint Inc
SAIL
$8.7B
$158K 0.01%
+11,901
New +$186K
HFFG icon
1506
HF Foods Group
HFFG
$81.8M
$157K 0.01%
84,935
+41,278
+95% +$79K
YRD
1507
Yiren Digital
YRD
$103M
$157K 0.01%
91,350
-17,884
-16% -$63.5K
CATX icon
1508
Perspective Therapeutics
CATX
$322M
$156K 0.01%
37,317
-48,895
-57% -$207K
CX icon
1509
Cemex
CX
$17.6B
$153K 0.01%
+13,339
New +$159K
PDM
1510
Piedmont Realty Trust
PDM
$1.22B
$153K 0.01%
+23,325
New +$181K
CNTY icon
1511
Century Casinos
CNTY
$32.6M
$152K 0.01%
109,562
HUMA icon
1512
Humacyte
HUMA
$182M
$152K 0.01%
+249,856
New +$260K
MYO icon
1513
Myomo
MYO
$41M
$150K 0.01%
221,476
-17,264
-7% -$14.1K
DCTH icon
1514
Delcath Systems
DCTH
$412M
$149K 0.01%
16,066
-51,712
-76% -$501K
TE
1515
T1 Energy
TE
$1.37B
$148K 0.01%
+33,772
New +$247K
CATO icon
1516
Cato Corp
CATO
$64.1M
$145K 0.01%
51,228
-1,660
-3% -$5.11K
XLO icon
1517
Xilio Therapeutics
XLO
$59.8M
$143K 0.01%
16,946
+6,377
+60% +$52.2K
ZDGE icon
1518
Zedge
ZDGE
$38.7M
$143K 0.01%
48,723
-4,685
-9% -$15.1K
SPAI
1519
Safe Pro Group Inc
SPAI
$79.2M
$143K 0.01%
+37,584
New +$183K
INTR icon
1520
Inter&Co
INTR
$2.45B
$142K 0.01%
17,777
+5,074
+40% +$44K
FWRG icon
1521
First Watch Restaurant Group
FWRG
$794M
$141K 0.01%
+13,419
New +$194K
API
1522
Agora
API
$337M
$140K 0.01%
39,415
-246,132
-86% -$1.04M
KYTX icon
1523
Kyverna Therapeutics
KYTX
$481M
$139K 0.01%
+16,161
New +$135K
ALXO icon
1524
ALX Oncology
ALXO
$272M
$138K 0.01%
68,987
-23,667
-26% -$45.1K
APLE icon
1525
Apple Hospitality REIT
APLE
$3.98B
$138K 0.01%
+11,986
New +$145K

Similar funds

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.